310 related articles for article (PubMed ID: 17313717)
21. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
22. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
23. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
[TBL] [Abstract][Full Text] [Related]
24. HFE genotype modifies the influence of heme iron intake on iron status.
Greenwood DC; Cade JE; Moreton JA; O'Hara B; Burley VJ; Randerson-Moor JA; Kukalizch K; Thompson D; Worwood M; Bishop DT
Epidemiology; 2005 Nov; 16(6):802-5. PubMed ID: 16222171
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and treatment of hereditary hemochromatosis: an update.
Kanwar P; Kowdley KV
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
[TBL] [Abstract][Full Text] [Related]
26. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
27. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
28. [Hereditary hemochromatosis].
Dantas W
Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
[TBL] [Abstract][Full Text] [Related]
29. A novel Y231del mutation of HFE in hereditary haemochromatosis provides in vivo evidence that the Huh-7 is a human haemochromatotic cell line.
Takano A; Niimi H; Atarashi Y; Sawasaki T; Terasaki T; Nakabayashi T; Kitajima I; Tobe K; Takahara T
Liver Int; 2011 Nov; 31(10):1593-7. PubMed ID: 22093335
[TBL] [Abstract][Full Text] [Related]
30. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
[TBL] [Abstract][Full Text] [Related]
31. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
[TBL] [Abstract][Full Text] [Related]
32. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
33. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
Nelson JE; Brunt EM; Kowdley KV;
Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
[TBL] [Abstract][Full Text] [Related]
34. Blood donors with hereditary hemochromatosis.
Røsvik AS; Ulvik RJ; Wentzel-Larsen T; Hervig T
Transfusion; 2010 Aug; 50(8):1787-93. PubMed ID: 20345568
[TBL] [Abstract][Full Text] [Related]
35. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis.
Hughes M; Vosylius P
Clin Lab Haematol; 2006 Oct; 28(5):357-9. PubMed ID: 16999731
[TBL] [Abstract][Full Text] [Related]
36. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy.
De Marco F; Liguori R; Giardina MG; D'Armiento M; Angelucci E; Lucariello A; Morante R; Cimino L; Galeota-Lanza A; Tarantino G; Ascione A; Budillon G; Vecchione R; Martinelli R; Matarazzo M; De Simone V
Clin Chem Lab Med; 2004 Jan; 42(1):17-24. PubMed ID: 15061375
[TBL] [Abstract][Full Text] [Related]
39. Examining the clinical use of hemochromatosis genetic testing.
Lanktree MB; Lanktree BB; Paré G; Waye JS; Sadikovic B; Crowther MA
Can J Gastroenterol Hepatol; 2015; 29(1):41-5. PubMed ID: 25706573
[TBL] [Abstract][Full Text] [Related]
40. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.
Kelleher T; Ryan E; Barrett S; Sweeney M; Byrnes V; O'Keane C; Crowe J
Gut; 2004 Aug; 53(8):1174-9. PubMed ID: 15247188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]